Western Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Western Wealth Management's VRTX Position: Q2 2026 in Review
Western Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 35% in Q2 2026, selling an estimated $257K and leaving 1,052 shares worth $523K. The position accounts for 0.02% of the portfolio, ranked #660.
Western Wealth Management first reported a position in VRTX in Q1 2022 and has held it in 13 quarters since. The position peaked at $728K in Q1 2026. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Western Wealth Management held 1,052 shares of Vertex Pharmaceuticals worth $523K as of Q2 2026.
- Western Wealth Management sold 579 Vertex Pharmaceuticals shares in Q2 2026, an estimated $257K.
- Vertex Pharmaceuticals made up 0.02% of Western Wealth Management's portfolio in Q2 2026, its #660 holding.
- Western Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 13 quarters since.
- Western Wealth Management's Vertex Pharmaceuticals position peaked at $728K in Q1 2026.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.